-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Transfer from | Pharmaceutical Mission Hills
On July 5, “Near Neighbor Bio,” a cutting-edge in the mRNA field, announced that it had completed more than 10 million yuan in seed + round financing, which was exclusively completed by Yuansheng Ventures
Public information shows that Neighbor Bio was established in March 2020, focusing on the research and development of mRNA drugs, with research areas covering infectious diseases, tumors and protein enhancement
Whether in vivo or in vitro, the delivery system is a necessary condition for intracellular delivery of mRNA to the treatment site
According to reports, in response to the problem of mRNA delivery, the Neighbors Biologics team used liposomes’ molecular design and nanoparticle structure control as its core ideas to strengthen the clinical safety of liposomal mRNA drugs and designed a “synergistic” effect.
Note: The original text has been deleted
Original title: Cutting-edge! Neighbor Biotechnology completes seed + round of financing to develop mRNA drugs
